首页 > 最新文献

International journal of clinical research & trials最新文献

英文 中文
Artificial Intelligence in Colorectal Polyp Detection and Characterization. 人工智能在结直肠息肉检测与表征中的应用。
Pub Date : 2021-01-01 DOI: 10.15344/2456-8007/2021/157
Alexander Le, Moro O Salifu, Isabel M McFarlane

Background: Over the past 20 years, the advancement of artificial intelligence (AI) and deep learning (DL) has allowed for fast sorting and analysis of large sets of data. In the field of gastroenterology, colorectal screening procedures produces an abundance of data through video and imaging. With AI and DL, this information can be used to create systems where automatic polyp detection and characterization is possible. Convoluted Neural Networks (CNNs) have proven to be an effective way to increase polyp detection and ultimately adenoma detection rates. Different methods of polyp characterization of being hyperplastic vs. adenomatous or non-neoplastic vs. neoplastic has also been investigated showing promising results.

Findings: The rate of missed polyps on colonoscopy can be as high as 25%. At the beginning of the 2000s, hand-crafted machine learning (ML) algorithms were created and trained retrospectively on colonoscopy images and videos, achieving high sensitivity, specificity, and accuracy of over 90% in many of the studies. Over time, the advancement of DL and CNNs has allowed algorithms to be trained on non-medical images and applied retrospectively to colonoscopy videos and images with similar results. Within the past few years, these algorithms have been applied in real-time colonoscopies and has shown mixed results, one showing no difference while others showing increased polyp detection.Various methods of polyp characterization have also been investigated. Through AI, DL, and CNNs polyps can be identified has hyperplastic/adenomatous or non-neoplastic/neoplastic with high sensitivity, specificity, and accuracy. One of the research areas in polyp characterization is how to capture the polyp image. This paper looks at different modalities of characterizing polyps such as magnifying narrow band imaging (NBI), endocytoscopy, laser-induced florescent spectroscopy, auto-florescent endoscopy, and white-light endoscopy.

Conclusions: Overall, much progress has been made in automatic detection and characterization of polyps in real time. Barring ethical or mass adoption setbacks, it is inevitable that AI will be involved in the field of GI, especially in colorectal polyp detection and identification.

背景:在过去的20年里,人工智能(AI)和深度学习(DL)的进步使得对大型数据集的快速分类和分析成为可能。在胃肠病学领域,结直肠筛查程序通过视频和成像产生丰富的数据。通过人工智能和深度学习,这些信息可用于创建自动息肉检测和表征系统。卷积神经网络(cnn)已被证明是提高息肉检测和最终腺瘤检测率的有效方法。不同的方法表征息肉增生与腺瘤或非肿瘤性与肿瘤性也进行了研究,显示出有希望的结果。结果:结肠镜检查息肉漏诊率可高达25%。在21世纪初,手工制作的机器学习(ML)算法被创建并在结肠镜检查图像和视频上进行回顾性训练,在许多研究中实现了超过90%的高灵敏度、特异性和准确性。随着时间的推移,深度学习和cnn的进步使得算法可以在非医学图像上进行训练,并回顾性地应用于结肠镜检查视频和图像,结果类似。在过去的几年中,这些算法已经应用于实时结肠镜检查,并显示出不同的结果,一种显示没有差异,而另一种显示增加了息肉的检测。还研究了各种表征息肉的方法。通过AI、DL和cnn可以识别息肉是增生性/腺瘤性还是非肿瘤性/肿瘤性,具有较高的敏感性、特异性和准确性。如何捕获息肉图像是息肉表征的研究热点之一。本文着眼于不同的方式表征息肉,如放大窄带成像(NBI),内吞镜,激光诱导荧光光谱,自动荧光内镜和白光内镜。结论:总的来说,在息肉的实时自动检测和表征方面取得了很大进展。除了伦理或大规模应用方面的挫折,人工智能将不可避免地进入胃肠道领域,特别是在结肠直肠息肉的检测和识别方面。
{"title":"Artificial Intelligence in Colorectal Polyp Detection and Characterization.","authors":"Alexander Le,&nbsp;Moro O Salifu,&nbsp;Isabel M McFarlane","doi":"10.15344/2456-8007/2021/157","DOIUrl":"https://doi.org/10.15344/2456-8007/2021/157","url":null,"abstract":"<p><strong>Background: </strong>Over the past 20 years, the advancement of artificial intelligence (AI) and deep learning (DL) has allowed for fast sorting and analysis of large sets of data. In the field of gastroenterology, colorectal screening procedures produces an abundance of data through video and imaging. With AI and DL, this information can be used to create systems where automatic polyp detection and characterization is possible. Convoluted Neural Networks (CNNs) have proven to be an effective way to increase polyp detection and ultimately adenoma detection rates. Different methods of polyp characterization of being hyperplastic vs. adenomatous or non-neoplastic vs. neoplastic has also been investigated showing promising results.</p><p><strong>Findings: </strong>The rate of missed polyps on colonoscopy can be as high as 25%. At the beginning of the 2000s, hand-crafted machine learning (ML) algorithms were created and trained retrospectively on colonoscopy images and videos, achieving high sensitivity, specificity, and accuracy of over 90% in many of the studies. Over time, the advancement of DL and CNNs has allowed algorithms to be trained on non-medical images and applied retrospectively to colonoscopy videos and images with similar results. Within the past few years, these algorithms have been applied in real-time colonoscopies and has shown mixed results, one showing no difference while others showing increased polyp detection.Various methods of polyp characterization have also been investigated. Through AI, DL, and CNNs polyps can be identified has hyperplastic/adenomatous or non-neoplastic/neoplastic with high sensitivity, specificity, and accuracy. One of the research areas in polyp characterization is how to capture the polyp image. This paper looks at different modalities of characterizing polyps such as magnifying narrow band imaging (NBI), endocytoscopy, laser-induced florescent spectroscopy, auto-florescent endoscopy, and white-light endoscopy.</p><p><strong>Conclusions: </strong>Overall, much progress has been made in automatic detection and characterization of polyps in real time. Barring ethical or mass adoption setbacks, it is inevitable that AI will be involved in the field of GI, especially in colorectal polyp detection and identification.</p>","PeriodicalId":73437,"journal":{"name":"International journal of clinical research & trials","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10524292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Evaluating Challenges and Opportunities for Healthcare Reform: A Book Review 评估医疗改革的挑战和机遇:一本书评
Pub Date : 2020-12-28 DOI: 10.15344/2456-8007/2020/155
Victoria L. Henglein, Samy I McFarlane
{"title":"Evaluating Challenges and Opportunities for Healthcare Reform: A Book Review","authors":"Victoria L. Henglein, Samy I McFarlane","doi":"10.15344/2456-8007/2020/155","DOIUrl":"https://doi.org/10.15344/2456-8007/2020/155","url":null,"abstract":"","PeriodicalId":73437,"journal":{"name":"International journal of clinical research & trials","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-12-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44441474","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
A Case Report: Rare Presentation of Intracranial Hemorrhage post Guillain Barré Syndrome 格林-巴利综合征后颅内出血1例
Pub Date : 2020-12-16 DOI: 10.38179/ijcr.v1i1.23
Sarah El Halabi, Jaafar Al Shami, Ghadir Hijazi, Zakaria Alameddine, M. Ghandour, A. Saad
Background: Guillain Barre Syndrome (GBS) is an autoimmune disease where antibodies attack the myelin sheath of peripheral nerves. The hallmark of the disease includes symmetrical quadriparesis, respiratory distress, and failure with subsequent need for mechanical ventilation. Most cases occur after a viral or bacterial infection. Other causes, such as intracranial hemorrhage, also exist, and several case studies report an association between these two pathologies.Case Report: In this report, we present the case of an elderly male patient with intracranial (IC) bleeding post-GBS. The patient was admitted to the hospital for dyspnea and diagnosed with pneumonia. When he started complaining of progressive bilateral ascending paralysis of his lower extremities, we performed a lumbar puncture, and he was diagnosed with GBS. We started him on intravenous immune globulins (IVIGs) immediately, but his weakness progressed to include his respiratory muscles, and he required mechanical ventilatory support with Intensive Care Unit (ICU) admission. We extubated him after two weeks, but he needed to be reintubated 24 hours later for a severely decreased level of consciousness. An urgent computed tomography scan of the brain showed IC bleeding. The patient developed a septic shock due to his pneumonia, which was refractory to antibiotics and vasopressors. He passed away a few weeks after that.Conclusion: Our case represents a unique type of association between IC hemorrhages and GBS, where the bleeding occurred several days after, as opposed to before GBS. It also reinforces the correlation between GBS and Intracranial bleeding and stresses the importance of having a high index of suspicion when facing either pathology since both have similar symptoms that may overlap or mask each other.
背景:格林-巴利综合征(GBS)是一种自身免疫性疾病,抗体攻击周围神经的髓鞘。该疾病的特征包括对称性四肢瘫、呼吸窘迫和随后需要机械通气的衰竭。大多数病例发生在病毒或细菌感染之后。其他原因,如颅内出血,也存在,一些病例研究报告了这两种病理之间的联系。病例报告:在此报告中,我们提出了一例老年男性患者颅内出血后gbs。病人因呼吸困难而入院,并被诊断为肺炎。当他开始抱怨他的下肢进行性双侧上升性麻痹时,我们给他做了腰椎穿刺,他被诊断为GBS。我们立即开始给他静脉注射免疫球蛋白(IVIGs),但他的虚弱进展到包括呼吸肌,在重症监护室(ICU)入院时需要机械通气支持。两周后我们拔管了他,但24小时后由于意识水平严重下降,他需要重新拔管。紧急电脑断层扫描显示颅内出血。患者因肺炎导致感染性休克,对抗生素和血管加压药物无效。几周后他去世了。结论:我们的病例代表了IC出血和GBS之间的一种独特的关联,出血发生在GBS发生几天之后,而不是之前。它还加强了GBS与颅内出血之间的相关性,并强调了在面对任何一种病理时高度怀疑的重要性,因为两者具有相似的症状,可能重叠或相互掩盖。
{"title":"A Case Report: Rare Presentation of Intracranial Hemorrhage post Guillain Barré Syndrome","authors":"Sarah El Halabi, Jaafar Al Shami, Ghadir Hijazi, Zakaria Alameddine, M. Ghandour, A. Saad","doi":"10.38179/ijcr.v1i1.23","DOIUrl":"https://doi.org/10.38179/ijcr.v1i1.23","url":null,"abstract":"\u0000Background: Guillain Barre Syndrome (GBS) is an autoimmune disease where antibodies attack the myelin sheath of peripheral nerves. The hallmark of the disease includes symmetrical quadriparesis, respiratory distress, and failure with subsequent need for mechanical ventilation. Most cases occur after a viral or bacterial infection. Other causes, such as intracranial hemorrhage, also exist, and several case studies report an association between these two pathologies.\u0000\u0000\u0000Case Report: In this report, we present the case of an elderly male patient with intracranial (IC) bleeding post-GBS. The patient was admitted to the hospital for dyspnea and diagnosed with pneumonia. When he started complaining of progressive bilateral ascending paralysis of his lower extremities, we performed a lumbar puncture, and he was diagnosed with GBS. We started him on intravenous immune globulins (IVIGs) immediately, but his weakness progressed to include his respiratory muscles, and he required mechanical ventilatory support with Intensive Care Unit (ICU) admission. We extubated him after two weeks, but he needed to be reintubated 24 hours later for a severely decreased level of consciousness. An urgent computed tomography scan of the brain showed IC bleeding. The patient developed a septic shock due to his pneumonia, which was refractory to antibiotics and vasopressors. He passed away a few weeks after that.\u0000\u0000\u0000Conclusion: Our case represents a unique type of association between IC hemorrhages and GBS, where the bleeding occurred several days after, as opposed to before GBS. It also reinforces the correlation between GBS and Intracranial bleeding and stresses the importance of having a high index of suspicion when facing either pathology since both have similar symptoms that may overlap or mask each other.\u0000","PeriodicalId":73437,"journal":{"name":"International journal of clinical research & trials","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72524523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COVID-19: What We Know So Far COVID-19:我们目前所知的情况
Pub Date : 2020-11-06 DOI: 10.38179/ijcr.v1i1.19
N. Emmanuel, V. Zibara, J. Saad, R. Iskandar, Rawad Abi Assaad, E. Ammanouil, Yara Bilen, G. Chidiac, N. Ahmar
Objective: Since the emergence of the COVID-19 pandemic at the end of 2019, the number of affected cases has not stopped rising. Similarly, the number of scientific publications and pre-prints has been increasing exponentially, with an effort to understand this disease more and find a proper solution. The purpose of this article is to review the current understanding of the novel coronavirus.Background: The latest COVID-19 pandemic caused by the SARS-CoV-2 has spread globally ever since it emerged in Wuhan's city in China. This rapidly spreading disease has changed our lives in unimaginable ways, spreading fear and uncertainty due to the lack of knowledge and the flooding with new information, which lacks the scientific method and cannot be critically appraised. The purpose of this article is to gather some of the best knowledge that has been published so far in a unified narrative review, making it easy for the scientific community to review the most accurate and recent understandings about COVID-19.Methods: We screened relevant articles using a specified number of keywords and specific databases, including PubMed and Embase. We selected peer-reviewed English published material related to the topic, except for a few pre-prints that we deemed necessary to include. We also screened the reference lists of these articles to find relevant publications with the same criteria.Discussion: This narrative overview comprises several subsections that discuss the epidemiology, virology, pathogenesis, clinical manifestations, diagnostic methods, and management of the disease. We also presented a section on the implications of the disease in pregnancy. We wrapped up the review with a special division regarding the response to COVID-19,  which has been diverse in different countries.Conclusion: COVID-19 has been a serious global health threat with a high transmission and case fatality rate, particularly in vulnerable populations. Epidemiologic models have so far guided the response, but they need to be interpreted carefully, with an understanding of their limitations. The disease's response has varied among different countries; with no current vaccine or standard treatment, the world stands in fear, maximizing preventive strategies to reduce the damages caused by this virus. This manuscript presents a summary of everything that is so far known about COVID-19 to make it easier for the medical community to overview the disease that has changed the world.
目的:2019年底新冠肺炎疫情发生以来,全球新增病例数持续上升。同样,科学出版物和预印本的数量呈指数级增长,努力更多地了解这种疾病并找到适当的解决办法。本文的目的是回顾目前对新型冠状病毒的认识。背景:由SARS-CoV-2引起的新冠肺炎大流行自中国武汉出现以来,已在全球蔓延。这种迅速蔓延的疾病以难以想象的方式改变了我们的生活,由于缺乏知识和新信息的泛滥而传播恐惧和不确定性,这些信息缺乏科学方法,无法进行批判性评价。本文的目的是收集迄今为止发表的一些最好的知识,以统一的叙述综述,使科学界能够轻松地回顾对COVID-19最准确和最新的理解。方法:我们使用特定数量的关键词和特定数据库筛选相关文章,包括PubMed和Embase。我们选择了与主题相关的同行评审的英文出版材料,除了一些我们认为有必要包括的预印本。我们还筛选了这些文章的参考文献列表,以找到具有相同标准的相关出版物。讨论:这个叙述概述包括几个小节,讨论流行病学、病毒学、发病机制、临床表现、诊断方法和疾病的管理。我们还提出了一节的影响,疾病在怀孕。我们以一个关于COVID-19应对措施的特别部门结束了审查,不同国家的应对措施各不相同。结论:COVID-19已成为严重的全球健康威胁,其传播率和病死率很高,特别是在弱势人群中。到目前为止,流行病学模型指导了应对措施,但需要仔细解释这些模型,并了解其局限性。不同国家对这种疾病的反应各不相同;由于目前没有疫苗或标准治疗方法,世界处于恐惧之中,最大限度地采取预防战略,以减少这种病毒造成的损害。本文概述了迄今为止关于COVID-19的所有信息,以便医学界更容易概述这种改变世界的疾病。
{"title":"COVID-19: What We Know So Far","authors":"N. Emmanuel, V. Zibara, J. Saad, R. Iskandar, Rawad Abi Assaad, E. Ammanouil, Yara Bilen, G. Chidiac, N. Ahmar","doi":"10.38179/ijcr.v1i1.19","DOIUrl":"https://doi.org/10.38179/ijcr.v1i1.19","url":null,"abstract":"\u0000Objective: Since the emergence of the COVID-19 pandemic at the end of 2019, the number of affected cases has not stopped rising. Similarly, the number of scientific publications and pre-prints has been increasing exponentially, with an effort to understand this disease more and find a proper solution. The purpose of this article is to review the current understanding of the novel coronavirus.\u0000\u0000\u0000Background: The latest COVID-19 pandemic caused by the SARS-CoV-2 has spread globally ever since it emerged in Wuhan's city in China. This rapidly spreading disease has changed our lives in unimaginable ways, spreading fear and uncertainty due to the lack of knowledge and the flooding with new information, which lacks the scientific method and cannot be critically appraised. The purpose of this article is to gather some of the best knowledge that has been published so far in a unified narrative review, making it easy for the scientific community to review the most accurate and recent understandings about COVID-19.\u0000\u0000\u0000Methods: We screened relevant articles using a specified number of keywords and specific databases, including PubMed and Embase. We selected peer-reviewed English published material related to the topic, except for a few pre-prints that we deemed necessary to include. We also screened the reference lists of these articles to find relevant publications with the same criteria.\u0000\u0000\u0000Discussion: This narrative overview comprises several subsections that discuss the epidemiology, virology, pathogenesis, clinical manifestations, diagnostic methods, and management of the disease. We also presented a section on the implications of the disease in pregnancy. We wrapped up the review with a special division regarding the response to COVID-19,  which has been diverse in different countries.\u0000\u0000\u0000Conclusion: COVID-19 has been a serious global health threat with a high transmission and case fatality rate, particularly in vulnerable populations. Epidemiologic models have so far guided the response, but they need to be interpreted carefully, with an understanding of their limitations. The disease's response has varied among different countries; with no current vaccine or standard treatment, the world stands in fear, maximizing preventive strategies to reduce the damages caused by this virus. This manuscript presents a summary of everything that is so far known about COVID-19 to make it easier for the medical community to overview the disease that has changed the world.\u0000","PeriodicalId":73437,"journal":{"name":"International journal of clinical research & trials","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80623446","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 14
A Case Report: Fatal Case of Disseminated Tuberculosis in a 24-year-old Male Patient with Crohn’s Disease 1例报告:24岁男性克罗恩病弥散性肺结核死亡病例
Pub Date : 2020-04-16 DOI: 10.38179/ijcr.v1i1.2
{"title":"A Case Report: Fatal Case of Disseminated Tuberculosis in a 24-year-old Male Patient with Crohn’s Disease","authors":"","doi":"10.38179/ijcr.v1i1.2","DOIUrl":"https://doi.org/10.38179/ijcr.v1i1.2","url":null,"abstract":"","PeriodicalId":73437,"journal":{"name":"International journal of clinical research & trials","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89201835","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Case Report: Case of Megacolon due to Bowel Intussusception in an Elderly Patient 老年患者肠套叠致巨结肠1例
Pub Date : 2020-04-16 DOI: 10.38179/ijcr.v1i1.3
{"title":"A Case Report: Case of Megacolon due to Bowel Intussusception in an Elderly Patient","authors":"","doi":"10.38179/ijcr.v1i1.3","DOIUrl":"https://doi.org/10.38179/ijcr.v1i1.3","url":null,"abstract":"","PeriodicalId":73437,"journal":{"name":"International journal of clinical research & trials","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75578807","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Prevalence of Malignancy Among Urban Black Rheumatoid Arthritis Patients. 城市黑人类风湿关节炎患者恶性肿瘤患病率。
Pub Date : 2020-01-01 DOI: 10.15344/2456-8007/2020/145
Isabel M McFarlane, Manjeet S Bhamra, Abhimnayu Amarnani, Su Yien Zhaz, Srinivas Kolla, Milena Rodriguez Alvarez, George Mo, Maya Srinivasan, Gil Hevroni, Talia Meisel, Abida Hasan, Marie S Baguidy, Michael Hadaddin, Adielle Melamed, Kristaq Koci, Nicholas Taklalsingh, Joshy Pathiparampil, Latoya Freeman, Ian Kaplan, Naureen Kabani, David J Ozeri, Elsie Watler, Mosab Frefer, Vytas Vaitkus, Keron Matthew, Fray Arroyo-Mercado, Helen Lyo, Aleksander Feoktistov, Randolph Sanchez, Faisal Soliman, Felix Reyes Valdez, Veena Dronamraju, Michael Trevisonno, Christon Grant, Guerrier Clerger, Kunfeng Sun, Khabbab Amin, Makeda Dawkins, Jason Green, Samir Fahmy, Apoorva Jayarangaiah, Stephen Anthony Waite, Aaliya Burza
Background Rheumatoid arthritis (RA) patients have an increased risk of malignancy with postulated risk factors that include chronic inflammation, smoking and the use of immunosuppressants have been postulated as drivers of higher malignancies rates. Our study aimed to describe the prevalence and type of malignancies encountered in an urban, predominantly Black RA patient population. Methods Cross sectional analysis of 1142 patients with RA diagnosis by ICD-codes of which 501 cases met the inclusion criteria for the study. Blacks accounted for 88.4% of the study population. Fifty-six patients had cancer recorded in their medical records and these cases were further reviewed for tumor type, timing of diagnosis and patient clinical characteristics. Results The cancer prevalence was 11.2% (56/501) in our Black RA population being studied. Mean age at cancer diagnosis was 59.9 ± 5.2 for the patients who developed cancer before RA diagnosis and 58.25 ± 16.02 for those who developed malignancy after RA diagnosis. There were 18 breast cancers, 4 colon and 4 cervical cancers; for lung, multiple myeloma, thyroid, squamous cell carcinoma and pancreas there were 3 cases each; for endometrial, Non-Hodgkin's lymphoma, meningioma and prostate, 2 cases each and 1 each for urinary bladder, esophageal adenocarcinoma, lymphoma, glioblastoma, liver, Hodgkin's lymphoma, sarcoma, ovary and renal cell carcinoma. No differences were found in years of RA duration, joint erosion, joint space narrowing or SENS score except for significantly higher ESR among the cancer group and RF seropositivity in the non-cancer group.Therapeutic modalities were not significantly different between the cancer and no cancer groups. Conclusion Breast cancer was the most prevalent malignancy among our Black RA population. Further studies are needed to identify the contributing factors to the malignancy risk of breast cancer in our Black RA population and whether it is gender-related since RA is more prevalence in women.
背景:类风湿关节炎(RA)患者患恶性肿瘤的风险增加,假定的危险因素包括慢性炎症、吸烟和使用免疫抑制剂被假定为恶性肿瘤发生率较高的驱动因素。我们的研究旨在描述在城市中遇到的恶性肿瘤的患病率和类型,主要是黑人RA患者人群。方法:对1142例经icd编码诊断为RA的患者进行横断面分析,其中501例符合本研究的纳入标准。黑人占研究人口的88.4%。56例患者的病历中有癌症记录,我们对这些病例的肿瘤类型、诊断时间和患者的临床特征进行了进一步的回顾。结果:黑人RA患病率为11.2%(56/501)。RA诊断前癌症患者的平均年龄为59.9±5.2岁,RA诊断后恶性肿瘤患者的平均年龄为58.25±16.02岁。有18例乳腺癌,4例结肠癌和4例宫颈癌;肺、多发性骨髓瘤、甲状腺、鳞状细胞癌、胰腺各3例;子宫内膜、非霍奇金淋巴瘤、脑膜瘤、前列腺癌各2例,膀胱、食管腺癌、淋巴瘤、胶质母细胞瘤、肝脏、霍奇金淋巴瘤、肉瘤、卵巢、肾细胞癌各1例。在RA持续时间、关节糜烂、关节间隙狭窄或SENS评分方面,除了癌症组的ESR和非癌症组的RF血清阳性显著升高外,没有发现差异。治疗方式在有癌组和无癌组之间没有显著差异。结论:乳腺癌是黑人类风湿关节炎人群中最常见的恶性肿瘤。在我们的黑人类风湿性关节炎人群中,需要进一步的研究来确定导致乳腺癌恶性风险的因素,以及是否与性别有关,因为类风湿性关节炎在女性中更流行。
{"title":"Prevalence of Malignancy Among Urban Black Rheumatoid Arthritis Patients.","authors":"Isabel M McFarlane,&nbsp;Manjeet S Bhamra,&nbsp;Abhimnayu Amarnani,&nbsp;Su Yien Zhaz,&nbsp;Srinivas Kolla,&nbsp;Milena Rodriguez Alvarez,&nbsp;George Mo,&nbsp;Maya Srinivasan,&nbsp;Gil Hevroni,&nbsp;Talia Meisel,&nbsp;Abida Hasan,&nbsp;Marie S Baguidy,&nbsp;Michael Hadaddin,&nbsp;Adielle Melamed,&nbsp;Kristaq Koci,&nbsp;Nicholas Taklalsingh,&nbsp;Joshy Pathiparampil,&nbsp;Latoya Freeman,&nbsp;Ian Kaplan,&nbsp;Naureen Kabani,&nbsp;David J Ozeri,&nbsp;Elsie Watler,&nbsp;Mosab Frefer,&nbsp;Vytas Vaitkus,&nbsp;Keron Matthew,&nbsp;Fray Arroyo-Mercado,&nbsp;Helen Lyo,&nbsp;Aleksander Feoktistov,&nbsp;Randolph Sanchez,&nbsp;Faisal Soliman,&nbsp;Felix Reyes Valdez,&nbsp;Veena Dronamraju,&nbsp;Michael Trevisonno,&nbsp;Christon Grant,&nbsp;Guerrier Clerger,&nbsp;Kunfeng Sun,&nbsp;Khabbab Amin,&nbsp;Makeda Dawkins,&nbsp;Jason Green,&nbsp;Samir Fahmy,&nbsp;Apoorva Jayarangaiah,&nbsp;Stephen Anthony Waite,&nbsp;Aaliya Burza","doi":"10.15344/2456-8007/2020/145","DOIUrl":"https://doi.org/10.15344/2456-8007/2020/145","url":null,"abstract":"Background Rheumatoid arthritis (RA) patients have an increased risk of malignancy with postulated risk factors that include chronic inflammation, smoking and the use of immunosuppressants have been postulated as drivers of higher malignancies rates. Our study aimed to describe the prevalence and type of malignancies encountered in an urban, predominantly Black RA patient population. Methods Cross sectional analysis of 1142 patients with RA diagnosis by ICD-codes of which 501 cases met the inclusion criteria for the study. Blacks accounted for 88.4% of the study population. Fifty-six patients had cancer recorded in their medical records and these cases were further reviewed for tumor type, timing of diagnosis and patient clinical characteristics. Results The cancer prevalence was 11.2% (56/501) in our Black RA population being studied. Mean age at cancer diagnosis was 59.9 ± 5.2 for the patients who developed cancer before RA diagnosis and 58.25 ± 16.02 for those who developed malignancy after RA diagnosis. There were 18 breast cancers, 4 colon and 4 cervical cancers; for lung, multiple myeloma, thyroid, squamous cell carcinoma and pancreas there were 3 cases each; for endometrial, Non-Hodgkin's lymphoma, meningioma and prostate, 2 cases each and 1 each for urinary bladder, esophageal adenocarcinoma, lymphoma, glioblastoma, liver, Hodgkin's lymphoma, sarcoma, ovary and renal cell carcinoma. No differences were found in years of RA duration, joint erosion, joint space narrowing or SENS score except for significantly higher ESR among the cancer group and RF seropositivity in the non-cancer group.Therapeutic modalities were not significantly different between the cancer and no cancer groups. Conclusion Breast cancer was the most prevalent malignancy among our Black RA population. Further studies are needed to identify the contributing factors to the malignancy risk of breast cancer in our Black RA population and whether it is gender-related since RA is more prevalence in women.","PeriodicalId":73437,"journal":{"name":"International journal of clinical research & trials","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10517469","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Impact of Sepsis Intervention Protocol (SIP) on Adherence to Three-hour and Six-hour Bundles and Mortality Outcomes in the Emergency Department. 脓毒症干预方案(SIP)对急诊科3小时和6小时捆绑治疗依从性和死亡率结果的影响
Pub Date : 2020-01-01 DOI: 10.15344/2456-8007/2020/149
Osagie Igiebor, Mohamed Nakeshbandi, Ninfa Mehta, Randi Ozaki, Michael Lucchesi, Maryanne Daley, Moro O Salifu, Samy I McFarlane

Sepsis is a commonly encountered diagnosis affecting nearly 1.7 million adults in the USA annually. According to Center for Disease Control (CDC), over 270,000 Americans die of sepsis each year and 1 in 3 hospital mortalities is attributed to sepsis. The Surviving Sepsis Campaign (SSC) Guidelines for management of severe sepsis and septic shock published in 2004 provide key elements in the treatment of sepsis that are organized into two bundles of care, the "resuscitation" and "management" bundles, including interventions to be accomplished within specified timeframes. In this quality improvement study, we implemented a sepsis intervention protocol (SIP) intended to increase adherence to 3-hour and 6-hour bundles, and to examine the impact on mortality of patients presenting with severe sepsis and septic shock in our emergency department. We analyzed data from our emergency department as reported to the New York State Department of Health (NYSDOH) from 2017Q2 to 2018Q2 (April 2017 -June 2018), the period prior to implementation of SIP, compared to data from 2018Q3 to 2019Q2 (July 2018 to June 2019) after implementation of SIP. The implementation of SIP resulted in increased3-hour and 6-hour bundle adherence and showed a clinically significant reduction of the mean pre-intervention hospital percent mortality of 40.3% to a mean post-intervention hospital percent mortality of 28.7%. A t-test analysis of the pre and post intervention mean hospital percent mortality revealed a reduction in mortality outcomes that was also statistically significant (p <0.05). Our study demonstrates that a well-designed and implemented SIP can increase bundle adherence and is highly effective in reducing mortality among high-risk population.

脓毒症是一种常见的诊断,每年影响美国近170万成年人。根据疾病控制中心(CDC)的数据,每年有超过27万美国人死于败血症,三分之一的医院死亡病例归因于败血症。2004年出版的《脓毒症生存运动(SSC)严重脓毒症和脓毒症休克管理指南》提供了脓毒症治疗的关键要素,分为两类护理,即“复苏”和“管理”,包括在规定时间内完成的干预措施。在这项质量改进研究中,我们实施了一项脓毒症干预方案(SIP),旨在提高3小时和6小时治疗包的依从性,并研究对急诊科出现严重脓毒症和脓毒性休克患者死亡率的影响。我们分析了2017年第二季度至2018年第二季度(2017年4月至2018年6月),即实施SIP之前,急诊科向纽约州卫生部(NYSDOH)报告的数据,并与实施SIP后的2018Q3至2019Q2(2018年7月至2019年6月)的数据进行了比较。SIP的实施增加了3小时和6小时捆绑治疗的依从性,并显示出临床显着降低了干预前平均医院死亡率40.3%到干预后平均医院死亡率28.7%。对干预前和干预后平均住院死亡率的t检验分析显示,死亡率结果的降低也具有统计学意义(p
{"title":"Impact of Sepsis Intervention Protocol (SIP) on Adherence to Three-hour and Six-hour Bundles and Mortality Outcomes in the Emergency Department.","authors":"Osagie Igiebor,&nbsp;Mohamed Nakeshbandi,&nbsp;Ninfa Mehta,&nbsp;Randi Ozaki,&nbsp;Michael Lucchesi,&nbsp;Maryanne Daley,&nbsp;Moro O Salifu,&nbsp;Samy I McFarlane","doi":"10.15344/2456-8007/2020/149","DOIUrl":"https://doi.org/10.15344/2456-8007/2020/149","url":null,"abstract":"<p><p>Sepsis is a commonly encountered diagnosis affecting nearly 1.7 million adults in the USA annually. According to Center for Disease Control (CDC), over 270,000 Americans die of sepsis each year and 1 in 3 hospital mortalities is attributed to sepsis. The Surviving Sepsis Campaign (SSC) Guidelines for management of severe sepsis and septic shock published in 2004 provide key elements in the treatment of sepsis that are organized into two bundles of care, the \"resuscitation\" and \"management\" bundles, including interventions to be accomplished within specified timeframes. In this quality improvement study, we implemented a sepsis intervention protocol (SIP) intended to increase adherence to 3-hour and 6-hour bundles, and to examine the impact on mortality of patients presenting with severe sepsis and septic shock in our emergency department. We analyzed data from our emergency department as reported to the New York State Department of Health (NYSDOH) from 2017Q2 to 2018Q2 (April 2017 -June 2018), the period prior to implementation of SIP, compared to data from 2018Q3 to 2019Q2 (July 2018 to June 2019) after implementation of SIP. The implementation of SIP resulted in increased3-hour and 6-hour bundle adherence and showed a clinically significant reduction of the mean pre-intervention hospital percent mortality of 40.3% to a mean post-intervention hospital percent mortality of 28.7%. A t-test analysis of the pre and post intervention mean hospital percent mortality revealed a reduction in mortality outcomes that was also statistically significant (p <0.05). Our study demonstrates that a well-designed and implemented SIP can increase bundle adherence and is highly effective in reducing mortality among high-risk population.</p>","PeriodicalId":73437,"journal":{"name":"International journal of clinical research & trials","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10549849","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Effects of Stevia Rebaudiana on Glucose Homeostasis, Blood Pressure and Inflammation: A Critical Review of Past and Current Research Evidence. 甜菊糖对葡萄糖稳态、血压和炎症的影响:对过去和现在研究证据的重要回顾。
Pub Date : 2020-01-01 DOI: 10.15344/2456-8007/2020/142
Justina Ray, Shweta Kumar, Daniel Laor, Naila Shereen, Felix Nwamaghinna, Alastair Thomson, Jessica Perez Perez, Lina Soni, Samy I McFarlane

The prevalence of obesity and its related comorbidities continues to rise in the United States and worldwide. Insulin resistance, increased inflammation and oxidative stress are the major pathogenic mechanisms involved in obesity-associated co-morbid conditions. Major efforts to curb the rising tide of obesity, including lifestyle modifications, anti-obesity medications and surgical interventions have shown minimal success. Therefore, introducing new methods to combat obesity, diabetes and associated disorders are desperately needed. Stevia rebaudiana, a natural, non-caloric sweetener has generated significant interest in the scientific community due to its effects on glucose homeostasis, blood pressure and inflammation, all known consequences of obesity. In this review, we assess the effects of Stevia on these parameters in humans as well as in animal models, highlighting its potential role as an effective intervention for the major cardiovascular risk factors associated with obesity.

在美国和世界范围内,肥胖及其相关合并症的患病率持续上升。胰岛素抵抗、炎症增加和氧化应激是肥胖相关合并症的主要致病机制。包括改变生活方式、抗肥胖药物和手术干预在内的控制不断上升的肥胖趋势的主要努力收效甚微。因此,迫切需要引入新的方法来对抗肥胖、糖尿病和相关疾病。甜菊糖是一种天然的无热量甜味剂,由于其对葡萄糖稳态、血压和炎症的影响,引起了科学界的极大兴趣,这些都是肥胖的已知后果。在这篇综述中,我们评估了甜菊糖在人类和动物模型中对这些参数的影响,强调了其作为与肥胖相关的主要心血管危险因素的有效干预的潜在作用。
{"title":"Effects of <i>Stevia Rebaudiana</i> on Glucose Homeostasis, Blood Pressure and Inflammation: A Critical Review of Past and Current Research Evidence.","authors":"Justina Ray,&nbsp;Shweta Kumar,&nbsp;Daniel Laor,&nbsp;Naila Shereen,&nbsp;Felix Nwamaghinna,&nbsp;Alastair Thomson,&nbsp;Jessica Perez Perez,&nbsp;Lina Soni,&nbsp;Samy I McFarlane","doi":"10.15344/2456-8007/2020/142","DOIUrl":"https://doi.org/10.15344/2456-8007/2020/142","url":null,"abstract":"<p><p>The prevalence of obesity and its related comorbidities continues to rise in the United States and worldwide. Insulin resistance, increased inflammation and oxidative stress are the major pathogenic mechanisms involved in obesity-associated co-morbid conditions. Major efforts to curb the rising tide of obesity, including lifestyle modifications, anti-obesity medications and surgical interventions have shown minimal success. Therefore, introducing new methods to combat obesity, diabetes and associated disorders are desperately needed. <i>Stevia rebaudiana</i>, a natural, non-caloric sweetener has generated significant interest in the scientific community due to its effects on glucose homeostasis, blood pressure and inflammation, all known consequences of obesity. In this review, we assess the effects of Stevia on these parameters in humans as well as in animal models, highlighting its potential role as an effective intervention for the major cardiovascular risk factors associated with obesity.</p>","PeriodicalId":73437,"journal":{"name":"International journal of clinical research & trials","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10536594","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 13
The Role of Echocardiography in Evaluation of Athletic Heart: A Scoping Study. 超声心动图在运动心脏评价中的作用:一项范围研究。
Pub Date : 2020-01-01 DOI: 10.15344/2456-8007/2020/153
Yitzhak Rosen, Hymie H Chera, Mohammed Abdulrazzaq, Mohammed Al-Sadawi, Boaz D Rosen, Joao Lima, Richard Grodman, Jason Lazar, Samy I McFarlane

Echocardiography can be a useful tool to evaluate athlete's heart in various sports. In this scoping review, we discuss some of the structural and functional changes of the right ventricle across different echocardiographic modes and techniques among individuals engaging in extreme athletic activity. We highlight the role of imaging in the evaluation of athlete's heart and describe similarities and differences between echocardiographic and cardiac MRI features related to acute and chronic athletic activity. We will also review novel echocardiographic parameters including speckle tracking and strain/strain rate imaging. Overall, we aim to present common echocardiographic parameters in elite sports population in order to facilitate better interpretation of their interpretations that may not necessarily be a distinct digression from these common features.

超声心动图是评价运动员在各种运动中的心脏状况的有效工具。在这篇综述中,我们讨论了参与极限运动的个体在不同超声心动图模式和技术下右心室的一些结构和功能变化。我们强调了成像在运动员心脏评估中的作用,并描述了与急性和慢性运动活动相关的超声心动图和心脏MRI特征之间的异同。我们还将回顾新的超声心动图参数,包括斑点跟踪和应变/应变率成像。总的来说,我们的目标是在精英运动人群中呈现常见的超声心动图参数,以便更好地解释他们的解释,这些解释可能不一定是与这些共同特征截然不同的离题。
{"title":"The Role of Echocardiography in Evaluation of Athletic Heart: A Scoping Study.","authors":"Yitzhak Rosen,&nbsp;Hymie H Chera,&nbsp;Mohammed Abdulrazzaq,&nbsp;Mohammed Al-Sadawi,&nbsp;Boaz D Rosen,&nbsp;Joao Lima,&nbsp;Richard Grodman,&nbsp;Jason Lazar,&nbsp;Samy I McFarlane","doi":"10.15344/2456-8007/2020/153","DOIUrl":"https://doi.org/10.15344/2456-8007/2020/153","url":null,"abstract":"<p><p>Echocardiography can be a useful tool to evaluate athlete's heart in various sports. In this scoping review, we discuss some of the structural and functional changes of the right ventricle across different echocardiographic modes and techniques among individuals engaging in extreme athletic activity. We highlight the role of imaging in the evaluation of athlete's heart and describe similarities and differences between echocardiographic and cardiac MRI features related to acute and chronic athletic activity. We will also review novel echocardiographic parameters including speckle tracking and strain/strain rate imaging. Overall, we aim to present common echocardiographic parameters in elite sports population in order to facilitate better interpretation of their interpretations that may not necessarily be a distinct digression from these common features.</p>","PeriodicalId":73437,"journal":{"name":"International journal of clinical research & trials","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10537379","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
期刊
International journal of clinical research & trials
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1